Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2025-12-29 @ 11:57 PM
Study NCT ID:
NCT06957561
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-04
First Post:
2025-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-26
First Submit QC Date:
None
Study First Post Date:
2025-05-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-26
Last Update Post Date:
2025-05-04
Last Update Post Date Type:
ACTUAL